Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent

Melissa Dodds; Patricia Hobday; Brittney Schultz; Sheilagh Maguiness

doi:10.1111/pde.13442

Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent

Melissa Dodds, Patricia Hobday, Brittney Schultz, Sheilagh Maguiness

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Subacute cutaneous lupus erythematosus is rare in children. Most patients respond well to conventional therapy with prednisone, hydroxychloroquine, or both. Other case reports and small series have reported successful clearance with rituximab in adults. We report an adolescent who obtained remission with rituximab after failing conventional therapy.

Original language	English (US)
Pages (from-to)	e189-e190
Journal	Pediatric Dermatology
Volume	35
Issue number	3
DOIs	https://doi.org/10.1111/pde.13442
State	Published - May 1 2018

Bibliographical note

Publisher Copyright:
© 2018 Wiley Periodicals, Inc.

Keywords

collagen vascular disorder
inflammatory disorders
systemic
therapy

Access

10.1111/pde.13442

OpenUrl availability

Full text

Cite this

@article{d5ed7c0bcf3940d59651cda4f31e686a,

title = "Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent",

abstract = "Subacute cutaneous lupus erythematosus is rare in children. Most patients respond well to conventional therapy with prednisone, hydroxychloroquine, or both. Other case reports and small series have reported successful clearance with rituximab in adults. We report an adolescent who obtained remission with rituximab after failing conventional therapy.",

keywords = "collagen vascular disorder, inflammatory disorders, systemic, therapy",

author = "Melissa Dodds and Patricia Hobday and Brittney Schultz and Sheilagh Maguiness",

note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2018",

month = may,

day = "1",

doi = "10.1111/pde.13442",

language = "English (US)",

volume = "35",

pages = "e189--e190",

journal = "Pediatric Dermatology",

issn = "0736-8046",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent

AU - Dodds, Melissa

AU - Hobday, Patricia

AU - Schultz, Brittney

AU - Maguiness, Sheilagh

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Subacute cutaneous lupus erythematosus is rare in children. Most patients respond well to conventional therapy with prednisone, hydroxychloroquine, or both. Other case reports and small series have reported successful clearance with rituximab in adults. We report an adolescent who obtained remission with rituximab after failing conventional therapy.

AB - Subacute cutaneous lupus erythematosus is rare in children. Most patients respond well to conventional therapy with prednisone, hydroxychloroquine, or both. Other case reports and small series have reported successful clearance with rituximab in adults. We report an adolescent who obtained remission with rituximab after failing conventional therapy.

KW - collagen vascular disorder

KW - inflammatory disorders

KW - systemic

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85044340137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044340137&partnerID=8YFLogxK

U2 - 10.1111/pde.13442

DO - 10.1111/pde.13442

M3 - Article

C2 - 29570834

AN - SCOPUS:85044340137

SN - 0736-8046

VL - 35

SP - e189-e190

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 3

ER -

Successful treatment of severe subacute cutaneous lupus erythematosus with rituximab in an adolescent

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this